Advertisement
Advertisement
CNTA
Centessa Pharmaceuticals plc - ADR
21.87
USD+0.54
+2.51%
Sep 17, 16:00 UTC -4
Closed
After-Market
21.85
-0.02
-0.07%
Centessa Pharmaceuticals plc - ADR Profile
About
Info & Links
CEO
Saurabh Saha
Headquarters
Cheshire, X0 WA14 2DT, UNITED KINGDOM
Industry
Sector
Website
Auditor
KPMG LLP
Share holders
6
Employees
77
Centessa Pharmaceuticals plc - ADR Statistics
Valuation Measures
Market Capitalization2
2.93B
Enterprise Value
2.99B
Enterprise Value/EBITDA(ttm)
-14.62
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
8.08
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
25.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
-43.56%
Return on Equity(ttm)
-40.39%
Return on Invested Capital(ttm)
-45.57%
Return on Assets(ttm)
-29.87%
Income Statement
Revenue(ttm)
15.00M
Revenue Per Share(ttm)
--
Gross Profit(ttm)
15.00M
EBITDA(ttm)3
-204.90M
Net Income Available to Common(ttm)
-230.37M
Diluted EPS(ttm)
-1.79
Share Statistics
Beta (5Y Monthly)
1.47
52-Week Change
32.84%
S&P 500 52-Week Change
17.14%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
--
Dividend Yield
0.00%
Float4
124.42M
% Held by Insiders
7.09%
% Held by Institutions
82.01%
Balance Sheet
Total Cash(mrq)
250.72M
Total Cash Per Share(mrq)
--
Total Debt(mrq)
109.55M
Total Debt/Equity(mrq)
31.76%
Current Ratio(mrq)
10.12%
Quick Ratio(mrq)
10.12%
Book Value Per Share(mrq)
2.58
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.60
Free Cash Flow(ytd)
-79.82M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement